Hybrid Lens Technology Complements Onefit ™ Scleral Lenses to Provide Full Continuum of Care for Irregular Cornea and Keratoconus
SAN RAMON, Calif. , Nov. 3, 2022 /PRNewswire/ — Deepening its commitment to expand specialty contact lens adoption in North America plus worldwide, CooperVision has added SynergEyes in order to its CooperVision Specialty EyeCare business unit. The Carlsbad, Calif. -based company is widely known for hybrid lens technologies and brands, which span the treatment of irregular cornea, presbyopia, and astigmatism.
This development broadens CooperVision’s already extensive range associated with products and services. The addition creates a complete portfolio for the treatment of keratoconus and irregular cornea in Northern America plus beyond, plus substantial opportunities to advance care for other common ocular conditions.
“Eye care practitioners are searching for ways to differentiate themselves, with a growing number embracing specialty contact lenses for their clinical and business advantages. Combining these two specialty segment experts provides a full range of options which delivers a continuum of treatment for keratoconus, ” said Juan Carlos Aragón, OD, President, CooperVision Specialty EyeCare. “SynergEyes offers a broad variety of specialized contact lenses, including proprietary cross lenses, complementing our popular Onefit ™ scleral lenses. Customers should quickly benefit from the blend of CooperVision and SynergEyes products, systems, support services, and people. ”
Since the first generation associated with SynergEyes crossbreed lenses came to market within 2005, the company has continued to improve the multifaceted technologies required for success. Its manufacturers include Duette ® , UltraHealth ® , plus SynergEyes ® iD Single Vision and Multifocal EDOF, as well as SynergEyes VS™ scleral lenses.
Over the next few years, manufacturing of SynergEyes products and materials will transition to CooperVision Specialty EyeCare’s recently opened production center in Gilbert, Ariz. GP Specialists, whom CooperVision acquired in 2021, has shared plans in order to move into that facility in 2023.
SynergEyes CEO Bob Ferrigno will serve as a consultant with the particular organization through early 2023 to assist with the changeover. Louise Sclafani , Z, FAAO, FSLS, Vice President of Professional Affairs for SynergEyes, will join the CooperVision Specialty EyeCare Americas team.
CooperVision Specialty EyeCare develops, manufactures, and provides access to an unmatched portfolio of industry-leading soft and custom rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea, and presbyopia management. The particular group’s brand names include Blanchard, EnsEyes, DOCTOR Specialists, No7 Contact Lenses, Paragon, Procornea, plus Soflex.
SynergEyes customers should continue to work with their current representatives. Terms of the transaction were not disclosed.
About CooperVision
CooperVision, a division associated with CooperCompanies (NYSE: COO ), is one of the world’s leading manufacturers of get in touch with lenses. The company produces a full array of daily disposable, two-week and monthly soft disposable lenses that feature advanced materials plus optics, and premium firm gas permeable lenses with regard to orthokeratology plus scleral styles. CooperVision has a strong heritage associated with addressing the particular toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers plus wearers. For more information, visit www.coopervision.com .
Regarding CooperCompanies
CooperCompanies (“Cooper”) is the global medical device company publicly traded on the NYSE (NYSE: COO ). Cooper operates via two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on eyesight care with a commitment in order to developing a wide range of high-quality products for lens wearers plus providing focused practitioner support. CooperSurgical is committed to advancing the particular health associated with women, babies and families with its diversified portfolio of services and products focusing on healthcare devices and fertility & genomics. Headquartered in San Ramon, Calif. , Cooper has the workforce associated with roughly 14, 000 along with products sold in over 100 countries. For more information, please visit www.coopercos.com .
Media Contact
Mike McDougall , APR, Fellow PRSA, McDougall Communications
[email protected] or +1-585-434-2150
SOURCE CooperVision
